Delaware Adult-Use Sales Miss First-Year Projections by Wide Margin

Revenue Gap and Regulatory Expectations

Delaware's adult-use program brought in roughly 60 percent of the revenue state officials forecast for the first twelve months. Regulators had projected $180 million in gross sales by April 2026. Actual receipts totaled approximately $108 million, according to figures from the Delaware Division of Alcohol and Tobacco Enforcement.

That's a $72 million miss. State budget planners had banked on $27 million in excise and sales tax revenue; actual collections came in near $16 million—a material hole for a state with a $5.2 billion annual budget.

Officials attributed the underperformance to slower-than-expected retail buildout, payment-processing friction, and a larger-than-anticipated gray market. Delaware launched with only four operational dispensaries statewide. By year-end, the count had risen to nine, still well short of the 15 locations regulators expected online by April 2026.

Point-of-Sale and Payment Infrastructure Challenges

Cash-only operations and limited POS integrations constrained transaction volume at most Delaware dispensaries. Seven of the nine active retailers operated without integrated debit solutions for at least six months of the program's first year. Banking access remained inconsistent despite state-level guidance encouraging financial institutions to serve licensed operators.

Dispensaries reported average transaction values 18 percent lower than projections. Industry consultants tied the gap directly to the cash ceiling effect: customers buying with cash tend to spend less per visit than those using cards. Delaware's lack of a state-chartered cannabis bank—unlike Michigan or Illinois—left operators relying on out-of-state credit unions or operating entirely in cash.

Seed-to-sale tracking via BioTrackTHC also experienced multi-week outages in July and November 2025, forcing manual compliance workflows that slowed inventory turns. Two dispensaries temporarily suspended sales during the November outage rather than risk reporting violations.

Medical-to-Adult-Use Cannibalization

Medical program sales declined 41 percent year-over-year as patients migrated to the adult-use channel. Delaware's medical registry dropped from 9,200 active cardholders in March 2025 to 5,400 by March 2026. Regulators had modeled a 25 percent attrition rate. The actual figure was nearly double.

That faster-than-expected shift eroded the dual-market revenue base. Medical sales, which carried a lower tax burden, fell from $22 million in fiscal 2024 to $13 million in fiscal 2025. Adult-use sales didn't fully backfill the gap, suggesting some former medical patients either reduced consumption or turned to unlicensed sources.

Industry observers noted that Delaware's 15 percent adult-use excise tax—on top of the state's 6.6 percent sales tax—created a price premium that gray-market sellers exploited. Neighboring Pennsylvania and Maryland maintain lower effective tax rates, and cross-border shopping became a documented behavior among Delaware consumers near state lines.

Licensing Bottlenecks and Equity Delays

Social equity applicants faced an average 11-month wait for conditional licenses, double the timeline state officials projected. Delaware's equity program reserved 60 percent of new retail licenses for applicants from communities disproportionately impacted by prohibition. Complex ownership-verification requirements and capital-access barriers slowed approvals.

Only two equity licensees opened stores in the first year. The other seven equity conditional licenses remained in pre-operational phases as of April 2026, awaiting final inspections, zoning clearances, or financing. That left the market dominated by the state's four legacy medical operators, which converted to hybrid med-rec models.

Equity advocates criticized the state's failure to provide low-interest loans or grants to bridge the capital gap. Delaware allocated $2 million to its Cannabis Equity Fund but disbursed only $340,000 in the first year, citing application-volume shortfalls and underwriting delays.

Gray Market Persistence

Law enforcement and regulators estimated that unlicensed sales still accounted for 35 to 40 percent of total cannabis consumption in Delaware. That's higher than the 20 percent gray-market share officials anticipated by year one. Illicit storefronts, delivery services advertising on social media, and person-to-person sales remained widespread, particularly in Wilmington and Dover.

Delaware's three-county geography and porous borders complicated enforcement. State Police reported 140 seizures of untagged cannabis products in the first year, but only 11 resulted in criminal charges. Civil penalties for unlicensed sales max out at $5,000 per violation—a figure industry groups called insufficient to deter organized operators.

Regulators acknowledged that price compression in the licensed market would take at least another 18 months. Delaware's wholesale flower prices averaged $2,800 per pound in early 2026, compared to $1,800 in Michigan and $2,200 in Illinois. Higher input costs and limited cultivation capacity kept retail prices elevated.

Operator Margins and Viability

Three of the nine active dispensaries reported negative EBITDA in their first six months of adult-use operations. High rent, compliance costs, and lower-than-modeled foot traffic squeezed margins. One equity licensee in Dover closed after five months, citing unsustainable burn rates and an inability to secure additional capital.

The underperformance isn't operator failure—it's a market-design problem, and the fix requires regulatory adjustments that typically take 12 to 18 months to implement.

Operators pointed to Delaware's ban on delivery as a structural disadvantage. Neighboring New Jersey and Maryland both allow licensed delivery, giving consumers in border regions more convenience options. Delaware legislators introduced a delivery bill in February 2026, but it stalled in committee.

Outlook and Policy Adjustments

State officials announced a working group in May 2026 to recommend policy changes aimed at closing the revenue gap. Priorities include expanding banking access, streamlining equity-license approvals, and potentially lowering the excise tax rate to improve price competitiveness. Recommendations are expected by September 2026.

Regulators also signaled openness to allowing consumption lounges and expanding product categories, including higher-potency edibles currently capped at 10 mg THC per package. Both moves could drive incremental revenue, though they require legislative action.

For a deeper look at Delaware's program structure and regulatory framework, see the CannIntel topic hub on Delaware's adult-use program.

The next inflection point: whether the state adjusts its tax structure before the end of fiscal 2026. If not, the revenue miss is likely to widen in year two.